ENTA — Enanta Pharmaceuticals Inc · rev $65.3M

Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.

Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.

Use this ENTA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ENTA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ENTA SEC filings page. Lician reads the product cache first so this HTML stays unique to Enanta Pharmaceuticals Inc even when a live quote feed is slow.

Enanta Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full ENTA income, balance, and cash tables.

  • Revenue$65.3M
  • Net Income-$81.9M
  • Total Assets$280.7M
  • Total Debt$0
  • Free Cash Flow-$32.2M

ENTA recent filings